|
Volumn 44, Issue 26, 2001, Pages 4661-4667
|
Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 PHENYLPYRIDINE DERIVATIVE;
CISPLATIN;
GLYCOPROTEIN P;
LIGAND;
PLATINUM COMPLEX;
PYRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
VERAPAMIL;
ANIMAL CELL;
ARTICLE;
CANCER CELL CULTURE;
CANCER RESISTANCE;
COMPLEX FORMATION;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG INHIBITION;
DRUG SYNTHESIS;
IC 50;
MOUSE;
NONHUMAN;
SARCOMA CELL;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL DIVISION;
CISPLATIN;
CRYSTALLOGRAPHY, X-RAY;
DRUG RESISTANCE, NEOPLASM;
DRUG SCREENING ASSAYS, ANTITUMOR;
FLOW CYTOMETRY;
MICE;
ORGANOPLATINUM COMPOUNDS;
P-GLYCOPROTEIN;
PYRIDINES;
SARCOMA;
TUMOR CELLS, CULTURED;
VERAPAMIL;
|
EID: 0035924233
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm010203d Document Type: Article |
Times cited : (110)
|
References (22)
|